Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Samanen

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1994
The in vivo pharmacological profile of the novel glycoprotein IIb/IIIa antagonist, SK&F 106760A J Nichols, J A Vasko, P F Koster, et al.
Thrombosis Research|July 15, 1994
The in vitro pharmacological profile of SK&F 106760, a novel GPIIB/IIIA antagonistA J Nichols, J A Vasko, R E Valocik, et al.
Journal of Medicinal Chemistry|October 16, 1992
Imidazole-5-acrylic acids: potent nonpeptide angiotensin II receptor antagonists designed using a novel peptide pharmacophore modelR M Keenan, J Weinstock, J A Finkelstein, et al.
Journal of Medicinal Chemistry|June 25, 1993
Potent nonpeptide angiotensin II receptor antagonists. 2. 1-(Carboxybenzyl)imidazole-5-acrylic acidsR M Keenan, J Weinstock, J A Finkelstein, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Discovery of an imidazopyridine-containing 1,4-benzodiazepine nonpeptide vitronectin receptor (alpha v beta 3) antagonist with efficacy in a restenosis modelR M Keenan, M A Lago, W H Miller, et al.
Journal of Medicinal Chemistry|March 3, 1999
Conformational preferences in a benzodiazepine series of potent nonpeptide fibrinogen receptor antagonistsR M Keenan, J F Callahan, J M Samanen, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1994
The in vivo pharmacological profile of the novel glycoprotein IIb/IIIa antagonist, SK&F 106760A J Nichols, J A Vasko, P F Koster, et al.
Thrombosis Research|July 15, 1994
The in vitro pharmacological profile of SK&F 106760, a novel GPIIB/IIIA antagonistA J Nichols, J A Vasko, R E Valocik, et al.
Journal of Medicinal Chemistry|October 16, 1992
Imidazole-5-acrylic acids: potent nonpeptide angiotensin II receptor antagonists designed using a novel peptide pharmacophore modelR M Keenan, J Weinstock, J A Finkelstein, et al.
Journal of Medicinal Chemistry|June 25, 1993
Potent nonpeptide angiotensin II receptor antagonists. 2. 1-(Carboxybenzyl)imidazole-5-acrylic acidsR M Keenan, J Weinstock, J A Finkelstein, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Discovery of an imidazopyridine-containing 1,4-benzodiazepine nonpeptide vitronectin receptor (alpha v beta 3) antagonist with efficacy in a restenosis modelR M Keenan, M A Lago, W H Miller, et al.
Journal of Medicinal Chemistry|March 3, 1999
Conformational preferences in a benzodiazepine series of potent nonpeptide fibrinogen receptor antagonistsR M Keenan, J F Callahan, J M Samanen, et al.
Pageof 1